Our Director for Liquid Biopsy Research, Pashtoon Kasi, M.D., recently published an article, “Using Circulating Tumor DNA in Colorectal Cancer: Current and Evolving Practices,” in the Journal of Clinical Oncology that is attracting a...
Read more
There is considerable variation in the management of mantle cell lymphoma across different clinical settings, and some strategies do not always conform with what might be expected, according to an analysis by investigators from Weill Cornell...
Read more
New Treatment Option for Advanced Urothelial Cancer Patients Shows Promise in a Phase 2 Clinical Trial A new treatment for advanced urothelial cancer was effective with tolerable side effects in an international, multi-center phase 2...
Read more
Phase 2 Trial Shows Cell Therapy May Prevent Infections in Leukemia Patients Treatment with a ready-made preparation of human immune cells helps prevent infections in people whose immune systems are temporarily weakened by leukemia treatment...
Read more
Cancer Patients with COVID-19 Have Similar Outcomes to Others Cancer patients who contracted COVID-19 during the height of the pandemic in New York City had similar outcomes to other patients with COVID-19, a study from researchers at Weill...
Read more
Rituximab Plus Lenalidomide More Effective Against Indolent Lymphoma Than Rituximab Alone The addition of an oral immunomodulatory drug to a commonly employed antibody therapy is more effective against chronic, indolent lymphoma than the antibody...
Read more